Position in RPRX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$23,787,939
+$6,177,721 QoQ
Shares Held
495,892
+8.8% QoQ
Ownership
0.086%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. RPRX ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503,564 | $224,861,468 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,152 | $84,335,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
171,797 | $56,842,473 | |
| 4 | INSM |
INSMED Inc
|
299,925 | $49,043,736 | |
| 5 | ARGX |
Argenx SE
|
61,418 | $44,850,494 | |
| 6 | RPRX |
Royalty Pharma plc
This page
|
495,892 | $23,787,939 | |
| 7 | GMAB |
Genmab A/S
|
862,301 | $23,135,535 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
678,518 | $18,794,948 |
All Filings in RPRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,787,939 | 495,892 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $17,610,218 | 455,751 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $15,433,271 | 437,451 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,516,960 | 97,612 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $3,233,224 | 103,862 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,703,047 | 66,760 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,910,225 | 67,523 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,020,601 | 76,625 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,695,003 | 88,739 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,109,077 | 39,483 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $579,276 | 21,344 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $476,039 | 15,486 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $570,174 | 15,825 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $510,835 | 12,926 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $502,169 | 12,498 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $425,739 | 10,127 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $332,095 | 8,524 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $252,967 | 6,348 | Shares | Sole | 2022-02-04 | |
| No filing history on record for this holder in this stock. | ||||||